Valentina De Lorenzi

Dr. Valentina De Lorenzi

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2014 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
GFGian Maria Sarra Ferraris
Gian Maria Sarra Ferraris
Carsten SchulteCarsten Schulte
Carsten Schulte
VBValentina Buttiglione
Valentina Buttiglione
VLValentina De Lorenzi
Valentina De Lorenzi
APAndrea Piontini
Andrea Piontini
NSNicolai Sidenius
Nicolai Sidenius
The urokinase‐type plasminogen activator receptor (uPAR) is a non‐integrin vitronectin (VN) cell adhesion receptor linked to the plasma membrane by a glycolipid anchor. Through structure–function analyses of uPAR, VN and integrins, we document that uPAR‐mediated cell adhesion to VN triggers a novel type of integrin signalling that is independent of integrin–matrix engagement. The signalling is fully active on VN mutants deficient in integrin binding site and is also efficiently transduced by integrins deficient in ligand binding. Although integrin ligation is dispensable, signalling is crucially dependent upon an active conformation of the integrin and its association with intracellular adaptors such as talin. This non‐canonical integrin signalling is not restricted to uPAR as it poses no structural constraints to the receptor mediating cell attachment. In contrast to canonical integrin signalling, where integrins form direct mechanical links between the ECM and the cytoskeleton, the molecular mechanism enabling the crosstalk between non‐integrin adhesion receptors and integrins is dependent upon membrane tension. This suggests that for this type of signalling, the membrane represents a critical component of the molecular clutch. See also: [RT Böttcher & R Fässler][1] (November 2014) ![][2] Cell adhesion mediated by uPAR and other adhesion receptors triggers non‐canonical integrin activation independent of integrin–ligand interactions. The cross‐talk between adhesion receptors and integrins is mediated by membrane tension. The EMBO Journal (2014) 33: 2458–2472 [1]: http://dx.doi.org/10.15252/embj.201489886 [2]: pending:yes

23 October 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
SRSerena Renzi
Serena Renzi
LDLuca Digiacomo
Luca Digiacomo
DPDaniela Pozzi
Daniela Pozzi
EQErica Quagliarini
Erica Quagliarini
EVElisabetta Vulpis
Elisabetta Vulpis
Giulio CaraccioloGiulio Caracciolo
Giulio Caracciolo
Lipid nanoparticles (LNPs) play a crucial role in addressing genetic disorders, and cancer, and combating pandemics such as COVID-19 and its variants. Yet, the ability of LNPs to effectively encapsulate large-size DNA molecules remains elusive. This is a significant limitation, as the successful delivery of large-size DNA holds immense potential for gene therapy. To address this gap, the present study focuses on the design of PEGylated LNPs, incorporating large-sized DNA, departing from traditional RNA and ionizable lipids. The resultant LNPs demonstrate a unique particle morphology. These particles were further engineered with a DNA coating and plasma proteins. This multicomponent bionanoconstruct exhibits enhanced transfection efficiency and safety in controlled laboratory settings and improved immune system evasion in in vivo tests. These findings provide valuable insights for the design and development of bionanoarchitectures for large-size DNA delivery, opening new avenues for transformative gene therapies.

5 September 2024 in ACS Pharmacology & Translational Science
Verified
Journal Article
Closed access
LDLuca Digiacomo
Luca Digiacomo
SRSerena Renzi
Serena Renzi
APAndrea Pirrottina
Andrea Pirrottina
HAHeinz Amenitsch
Heinz Amenitsch
VLValentina De Lorenzi
Valentina De Lorenzi
Giulio CaraccioloGiulio Caracciolo
Giulio Caracciolo

17 May 2016 in EMBO Reports
Verified
Journal Article
Closed access
PDF file
VLValentina De Lorenzi
Valentina De Lorenzi
GFGian Maria Sarra Ferraris
Gian Maria Sarra Ferraris
JMJeppe B Madsen
Jeppe B Madsen
MLMichela Lupia
Michela Lupia
PAPeter A Andreasen
Peter A Andreasen
NSNicolai Sidenius
Nicolai Sidenius

1 December 2015 in Data in Brief
Verified
Journal Article
Open access
BZBaoyu Zhao
Baoyu Zhao
SGSonu Gandhi
Sonu Gandhi
CYCai Yuan
Cai Yuan
ZLZhipu Luo
Zhipu Luo
RLRui Li
Rui Li
Michael PlougMichael Ploug
Michael Ploug
The urokinase-type plasminogen activator receptor (uPAR or CD87) is a glycolipid-anchored membrane protein often expressed in the microenvironment of invasive solid cancers and high levels are generally associated with poor patient prognosis (Kriegbaum et al., 2011 [1]). uPAR is organized as a dynamic modular protein structure composed of three homologous Ly6/uPAR domains (LU).This internally flexible protein structure of uPAR enables an allosteric regulation of the interactions with its two principal ligands: the serine protease urokinase-type plasminogen activator (uPA) and the provisional matrix protein vitronectin (Vn) (Mertens et al., 2012; Gårdsvoll et al., 2011; Madsen et al., 2007 [2-4]). The data presented here relates to the non-covalent trapping of one of these biologically relevant uPAR-conformations by a novel class of monoclonal antibodies (Zhao et al., 2015 [5]) and to the general mapping of the topographic epitope landscape on uPAR. The methods required to achieve these data include: (1) recombinant expression and purification of a uPAR-hybrid protein trapped in the desired conformation [patent; WO 2013/020898 A12013]; (2) developing monoclonal antibodies with unique specificities using this protein as antigen; (3) mapping the functional epitope on uPAR for these mAbs by surface plasmon resonance with a complete library of purified single-site uPAR mutants (Zhao et al., 2015; Gårdsvoll et al., 2006 [5,6]); and finally (4) solving the three-dimensional structures for one of these mAbs by X-ray crystallography alone and in complex with uPAR [deposited in the PDB database as 4QTH and 4QTI, respectively].

1 March 2015 in Journal of Molecular Biology
Verified
Journal Article
Closed access
BZBaoyu Zhao
Baoyu Zhao
Sonu GandhiSonu Gandhi
Sonu Gandhi
CYCai Yuan
Cai Yuan
ZLZhipu Luo
Zhipu Luo
RLRui Li
Rui Li
Michael PlougMichael Ploug
Michael Ploug